The effect of mifepristone, a potent progesterone receptor antagonist,
on the reproductive function during early pregnancy in rats was exami
ned. A single dose of this drug (10 mg/kg) was injected s.c. at 1200 h
on day 4 (Group I), day 7 (Group Il) or day 10 (Group III) of pregnan
cy. Gestation was interrupted and the vaginal cytology showed a typica
l proestrus condition two days after mifepristone treatment in all the
groups. When compared with cycling proestrus rats, serum LH concentra
tions at 1800 h in the mifepristone-induced proestrus were lower in Gr
oup I, similar in Group II and higher in Group III, and serum prolacti
n (PRL) values were lower in Group I, but not different in Groups II a
nd III. Serum progesterone levels were higher in the three experimenta
l groups when compared with cycling proestrus rats, and similar to tha
t of pregnant rats. Rats in Group I showed a significantly lower sexua
l receptivity and ovulation rate when compared with Groups II and III
or cycling proestrus rats. Most of the mifepristone-treated rats that
copulated during the night of the induced proestrus did not become pre
gnant and showed a delayed pseudopregnancy-like condition. These resul
ts indicate that mifepristone administered in a single dose to early p
regnant rats terminates pregnancy and induces a proestrus condition tw
o days after treatment followed by successful postovulatory contracept
ion. The mifepristone-induced proestrus is characterized by a differen
tial pattern of serum LH, PRL and progesterone concentrations, mating
behavior and ovulation rates, depending on the day of pregnancy when m
ifepristone is administered.